BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Adverum Biotechnologies (NASDAQ:ADVM)

1 post

Biotech NewsAdverum (ADVM) Could Soar 460% With $19.75 Target

  • BioTech Health X
  • September 7, 2025
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) is a clinical-stage biotechnology company pioneering the development of gene therapies for ocular diseases…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Adverum (ADVM) Could Soar 460% With $19.75 Target
  • Spero Therapeutics (SPRO) Surges After 200% Stock Jump on Phase 3 Success
  • Tiziana (TLSA) Surges 143% in 2025
  • OKYO Pharma (OKYO) Surges on 75% Pain Reduction in Phase 2 Trial
  • Twist Bioscience (TWST) Eyes 46% Upside with $40 Analyst Target
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • September 7, 2025
    Adverum (ADVM) Could Soar 460% With $19.75 Target
    • September 7, 2025
    Spero Therapeutics (SPRO) Surges After 200% Stock Jump on Phase 3 Success
    • September 7, 2025
    Tiziana (TLSA) Surges 143% in 2025
    • September 7, 2025
    OKYO Pharma (OKYO) Surges on 75% Pain Reduction in Phase 2 Trial
    • September 7, 2025
    Twist Bioscience (TWST) Eyes 46% Upside with $40 Analyst Target
Recent Posts
  • United Therapeutics (UTHR) Tyvaso DPI Sales Hit $315.2M, Up 22% YoY
    • September 7, 2025
  • Instil Bio (TIL) Skyrockets 180% in One Year
    • September 7, 2025
  • Ideaya (IDYA)’s $530M Servier Deal Could Transform Cancer Care
    • September 7, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (375)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top